Hims & Hers Weight Loss

Hims & Hers is one of the largest telehealth platforms in the United States, serving millions of patients across all 50 states. In March 2026, Hims & Hers made a major strategic shift by partnering directly with Novo Nordisk to offer FDA-approved Wegovy (including the new oral pill form) and Ozempic, discontinuing compounded GLP-1 products in favour of branded medications. The weight loss membership starts at $39 for the first month and $149 per month ongoing, giving patients access to licensed provider consultations within 24-48 hours, prescription management, medication shipped to their door, and ongoing care team messaging. The platform is available in all 50 US states, making it one of the most accessible options for GLP-1 treatment nationally. Hims & Hers supports both insurance and cash-pay patients and accepts FSA and HSA payments.